Table 35.
Availability and scope of guidelines for the assessment and treatment of osteoporosis in the EU [IOF audit]
| Developed (year) | Scopea | AGREE criteria | Score | |
|---|---|---|---|---|
| Austria | 2010 | PMW, men, GIOP | 5 | 8 |
| Belgium | 2005–11 | PMW, men, GIOP | 4 | 7 |
| Bulgaria | 2007 | PMW, men, GIOP | 6 | 9 |
| Cyprus | na | – | 0 | 0 |
| Czech Republic | 2003–10 | PMW, GIOP | 4 | 6 |
| Denmark | 2009 | PMW | 4 | 5 |
| Estonia | 2012 | PMW, men, GIOP | 5 | 8 |
| Finland | 2013 | PMW, men, GIOP | 7 | 10 |
| France | 2012 | PMW, men, GIOP | 5 | 6 |
| Germany | 2009 | PMW, men, GIOP | 7 | 10 |
| Greece | 2009–12 | PMW, men, GIOP | 5 | 8 |
| Hungary | 2003–11 | PMW, men, GIOP | 5 | 8 |
| Ireland | 2011 | PMW, men | 1 | 3 |
| Italy | −2011 | PMW, men, GIOP | 7 | 10 |
| Latvia | 2011 | PMW, men, GIOP | 7 | 10 |
| Lithuania | 2011 | PMW | 7 | 7 |
| Luxemburg | 2010 | PMW | 7 | 7 |
| Malta | na | – | 0 | 0 |
| Netherlands | 2011–12 | PMW, men, GIOP | 7 | 10 |
| Poland | 2011–12 | PMW, men, GIOP | 3 | 6 |
| Portugal | 2011 | PMW | 7 | 8 |
| Romania | 2011 | PMW, men, GIOP | 6 | 9 |
| Slovakia | 2006–10 | PMW, GIOP | 7 | 9 |
| Slovenia | 2002 | PMW | 2 | 3 |
| Spain | 2004–11 | PMW, men, GIOP | 4.5 | 6.5 |
| Sweden | 2008 | PMW, men, GIOP | 7 | 10 |
| UKb | 2008 | PMW, men, GIOP | 7 | 10 |
a PMW postmenopausal women, GIO glucocorticoid-induced osteoporosis
bRelates to guidance provided by the National Osteoporosis Guidelines Group [4]. National guidance with less scope also available from NICE [5–7]